Abstract:Methicillin Resistant Staphylococcus aureus (MRSA) is an emerging multidrug resistant bug worldwide. Knowing prevalence of MRSA is important to know for choosing empiric therapy and to screen colonized patients or staff. As Staphylococcus aureus is most common among pus samples, we have selected to do this study in this region. All clinical pus samples after receiving to Microbiology department, immediately inoculated in basal media such as Nutrient agar, Macconkey agar, Blood agar, Brain Heart Infusion Broth and selective media including mannitol salt agar DNAse agar. All Media plates after inoculation were incubated for 24 hours at 37 0 C. Out of 136, 59 (43.3%) were Staphylococcus aureus and MRSA was 17 (28.8%). In the present study, 20.3% were staphylococcal isolates sensitive to penicillin, 45.7% were sensitive to erythromycin, 42.3% were sensitive to clindamycin, 71.1% were sensitive to cefoxitin & cotrimoxazole, 30.5% were sensitive to ciprofloxacin, 88.1% were sensitive to gentamicin, 96.6% were sensitive to linezolid and 100% isolates were sensitive to tigecycline, teicoplanin and vancomycin. Guidelines for the prevention and control of MRSA should be followed in hospital care settings. Screening of MRSA should make a definite policy on all seriously ill patients after admission.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2025 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.